Abstract: Spring viraemia of carp virus (SVCV), a pathogen with significant economic impacts on global aquaculture, necessitates the development of rapid, sensitive diagnostic tools for effective disease management. This study presents two innovative detection methods that integrate recombinase-aided amplification (RAA) with CRISPR/Cas12a technology: the One-Pot RAA-CRISPR/Cas12a fluorescence assay and the RAA-CRISPR/Cas12a Lateral Flow Dipstick (LFD) assay. By targeting the highly conserved glycoprotein (G) gene of SVCV, optimized RAA primers and CRISPR RNA (crRNA) were designed. Additionally, a sucrose-stabilized biphasic reaction system was developed to facilitate seamless one-pot amplification and detection while minimizing the risk of and simplifying operational procedures. The fluorescence-based method exploits trans-cleavage activity of Cas12a to generate detectable fluorescent signals, while the LFD assay employs a FAM-biotin dual-labeled ssDNA probe for visual detection via colloidal gold accumulation on lateral flow strips. Sensitivity analysis revealed detection limits of 102 copies/μL for the fluorescence assay and 100 copies/μL for the LFD assay, representing a 10–1000-fold improvement over traditional nested PCR (103 copies/μL). Specificity testing confirmed no cross-reactivity with common fish pathogens, such as KHV, CyHV-2, GCRV-Ⅰ, GCRV-Ⅱ, GCRV-Ⅲ, or Aeromonas hydrophila. Clinical validation involving 30 samples yielded 100% concordance with results obtained from the national standard PCR protocol. This portable, instrument-free platform streamlines on-site SVCV detection in aquaculture settings, particularly in resource-constrained environments, by reducing operational complexity and assay time to 90 minutes. The dual-modality design—offering both quantitative fluorescence and naked-eye colorimetric readouts—supports the critical objectives of early viral detection, rapid intervention, and biosecurity management, positioning it as a transformative tool for global aquatic disease surveillance.